161 related articles for article (PubMed ID: 14744610)
1. In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.
de Lago E; Ligresti A; Ortar G; Morera E; Cabranes A; Pryce G; Bifulco M; Baker D; Fernandez-Ruiz J; Di Marzo V
Eur J Pharmacol; 2004 Jan; 484(2-3):249-57. PubMed ID: 14744610
[TBL] [Abstract][Full Text] [Related]
2. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
4. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
Vlachou S; Nomikos GG; Panagis G
Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
[TBL] [Abstract][Full Text] [Related]
5. Development of the first potential covalent inhibitors of anandamide cellular uptake.
Schiano Moriello A; Balas L; Ligresti A; Cascio MG; Durand T; Morera E; Ortar G; Di Marzo V
J Med Chem; 2006 Apr; 49(7):2320-32. PubMed ID: 16570928
[TBL] [Abstract][Full Text] [Related]
6. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ
J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels.
de Lago E; Petrosino S; Valenti M; Morera E; Ortega-Gutierrez S; Fernandez-Ruiz J; Di Marzo V
Biochem Pharmacol; 2005 Aug; 70(3):446-52. PubMed ID: 15963472
[TBL] [Abstract][Full Text] [Related]
9. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.
de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Viso A; López-Rodríguez ML; Ramos JA
Eur J Pharmacol; 2002 Aug; 449(1-2):99-103. PubMed ID: 12163112
[TBL] [Abstract][Full Text] [Related]
10. New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis.
Ligresti A; Cascio MG; Pryce G; Kulasegram S; Beletskaya I; De Petrocellis L; Saha B; Mahadevan A; Visintin C; Wiley JL; Baker D; Martin BR; Razdan RK; Di Marzo V
Br J Pharmacol; 2006 Jan; 147(1):83-91. PubMed ID: 16284631
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.
Mestre L; Correa F; Arévalo-Martín A; Molina-Holgado E; Valenti M; Ortar G; Di Marzo V; Guaza C
J Neurochem; 2005 Mar; 92(6):1327-39. PubMed ID: 15748152
[TBL] [Abstract][Full Text] [Related]
12. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.
Price TJ; Patwardhan AM; Flores CM; Hargreaves KM
Neuropharmacology; 2005 Jul; 49(1):25-39. PubMed ID: 15992578
[TBL] [Abstract][Full Text] [Related]
13. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.
Hillard CJ; Shi L; Tuniki VR; Falck JR; Campbell WB
J Mol Neurosci; 2007 Sep; 33(1):18-24. PubMed ID: 17901541
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.
Soria-Gómez E; Matias I; Rueda-Orozco PE; Cisneros M; Petrosino S; Navarro L; Di Marzo V; Prospéro-García O
Br J Pharmacol; 2007 Aug; 151(7):1109-16. PubMed ID: 17549045
[TBL] [Abstract][Full Text] [Related]
15. A catalytically silent FAAH-1 variant drives anandamide transport in neurons.
Fu J; Bottegoni G; Sasso O; Bertorelli R; Rocchia W; Masetti M; Guijarro A; Lodola A; Armirotti A; Garau G; Bandiera T; Reggiani A; Mor M; Cavalli A; Piomelli D
Nat Neurosci; 2011 Nov; 15(1):64-9. PubMed ID: 22101642
[TBL] [Abstract][Full Text] [Related]
16. Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.
Khasabova IA; Holman M; Morse T; Burlakova N; Coicou L; Harding-Rose C; Simone DA; Seybold VS
Neurobiol Dis; 2013 Oct; 58():19-28. PubMed ID: 23644187
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility.
Maccarrone M; Fride E; Bisogno T; Bari M; Cascio MG; Battista N; Finazzi Agrò A; Suris R; Mechoulam R; Di Marzo V
Mol Hum Reprod; 2005 Jan; 11(1):21-8. PubMed ID: 15563449
[TBL] [Abstract][Full Text] [Related]
18. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
de Lago E; de Miguel R; Lastres-Becker I; Ramos JA; Fernández-Ruiz J
Brain Res; 2004 May; 1007(1-2):152-9. PubMed ID: 15064146
[TBL] [Abstract][Full Text] [Related]
19. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.
Ortar G; Cascio MG; Moriello AS; Camalli M; Morera E; Nalli M; Di Marzo V
Eur J Med Chem; 2008 Jan; 43(1):62-72. PubMed ID: 17452063
[TBL] [Abstract][Full Text] [Related]
20. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
